🏅 FDA Orphan Designation

Actimmune

Interferon gamma 1-b

Manufacturer: Horizon Therapeutic Ireland DAC

Indicated for:

Chronic granulomatous diseaseOrphanAutosomal recessive malignant osteopetrosisOrphan

FDA-Approved Indications (2)

Chronic granulomatous diseaseOrphan Designation

Autosomal recessive malignant osteopetrosisOrphan Designation

Delaying time to disease progression in patients with severe, malignant osteopetrosis.

Indications & Usage

1 INDICATIONS AND USAGE ACTIMMUNE is indicated for reducing the frequency and severity of serious infections associated with Chronic Granulomatous Disease (CGD). ACTIMMUNE is indicated for delaying time to disease progression in patients with severe, malignant osteopetrosis (SMO). ACTIMMUNE is an interferon gamma indicated for: Reducing the frequency and severity of serious infections associated with Chronic Granulomatous Disease (CGD) ( 1 ) Delaying time to disease progression in patients with severe, malignant osteopetrosis (SMO) ( 1 )

💙 Support Programs

View all →

ACTIMMUNE

Horizon --- **Verification of current ownership:** Actimmune (interferon gamma-1b) is a biologic drug used to treat chronic granulomatous disease and malignant osteopetrosis. The rights to the drug we

Copay card ↗Apply ↗

Actimmune

Horizon Therapeutic Ireland DAC

Apply ↗

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.